Literature DB >> 29561309

Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review.

Philippe Rochigneux1,2, Nicolas Schleinitz3, Mikael Ebbo3, Marie Aymonier4, Bertrand Pourroy5, Romain Boissier6, Sébastien Salas1, Jean-Laurent Deville1.   

Abstract

Docetaxel is an antimicrotubules cytotoxic agent prescribed widely by medical oncologists in multiple tumor types (breast, lung, prostate, stomach, head, and neck). However, the side effects of docetaxel are numerous (cytopenia, peripheral edema, myalgia, arthralgia, alopecia, and sensitive neuropathy) and recent concerns have been raised about neutropenic enterocolitis in France. Here, we report the case of a 57-year-old patient with metastatic prostatic cancer, who developed a severe myositis and fasciitis grade IV 1 week after his second docetaxel infusion. We reviewed the five cases of docetaxel-related myositis described in the literature, and found that most of them occurred in patients with diabetes (n=5/5) or hypertension (n=4/5). A vascular toxicity may explain this severe complication, and patients with diabetes or hypertension should be monitored closely in the context of a docetaxel chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29561309     DOI: 10.1097/CAD.0000000000000620

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  3 in total

1.  A rare case of docetaxel-induced myositis in a patient with a lung adenocarcinoma.

Authors:  Akane Ishida; Ayumi Ushio; Masao Hashimoto; Satoru Ishii; Go Naka; Motoyasu Iikura; Shinyu Izumi; Masayuki Hojo; Haruhito Sugiyama
Journal:  Thorac Cancer       Date:  2022-05-20       Impact factor: 3.223

2.  SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer.

Authors:  Yu-Jeong Choi; Kangwook Lee; Ji-Hye Yoon; Sung-Gook Cho; Yun-Gyeong Kim; Miso Jeong; Hyun-Ha Hwang; Seo Yeon Lee; Se-Eun Jung; Seong-Gyu Ko
Journal:  Biomed Res Int       Date:  2022-05-05       Impact factor: 3.246

3.  Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells.

Authors:  Changcheng Wang; Jia Guo; Zeng'An Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.